To enrich for clinically significant breast cancer cases, we only included samples from cases (n = 442, for n = 423 SNP data were available) that had at least one poor prognostic feature (tumour >2 cm, node positive, grade 3, or ER negative; detailed characteristics shown in Supplementary Table 2). This evidence concerns the gene ESR1 and breast carcinoma.